Indivior Pharmaceuticals, Inc.
Indivior Pharmaceuticals, Inc. scores highest on Torque (98) and lowest on Price (39). Its PosiPenta is 68.09 out of 100, better than most similar companies.
On the Penta Grid this week, Indivior Pharmaceuticals, Inc. is Grid #30 of 837 in the Healthcare sector in United States, and Grid #87 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Indivior Pharmaceuticals, Inc. | 68.09 | 39 | 79 | 74 | 98 | 51 |
| ICU Medical, Inc. | 62.73 | 33 | 91 | 83 | 52 | 55 |
| Arcutis Biotherapeutics, Inc. | 57.65 | 7 | 87 | 90 | 58 | 46 |
| Integer Holdings Corporation | 66.39 | 42 | 82 | 100 | 52 | 56 |
| Relay Therapeutics, Inc. | 46.27 | 17 | 30 | 81 | 60 | 44 |
| Edgewise Therapeutics, Inc. | 48.33 | 7 | 30 | 81 | 66 | 58 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 11.63 |
| P/B ratio | -18.50 |
EEarnings
| Trailing EPS | ₹264.25 |
| Forward EPS | ₹462.52 |
NNitro
| Price | 3073.50 |
| 52-week high | 4054.75 |
| 52-week low | 2246.64 |
| Fall from 52-week high | 24.2% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | -3.55 |
AAnchor
| Beta (price swings) | 1.18 |
| Market cap | ₹36,277 Cr |
| Insider holding | 1.80% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Indivior Pharmaceuticals, Inc.'s PosiPenta score?
Indivior Pharmaceuticals, Inc.'s PosiPenta is 68.09 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Indivior Pharmaceuticals, Inc. stand on the Penta Grid?
On the Penta Grid this week, Indivior Pharmaceuticals, Inc. is Grid #30 of 837 in the Healthcare sector in United States, and Grid #87 of 4,000 in United States.
Which PosiPenta pillar is strongest for Indivior Pharmaceuticals, Inc.?
Torque (durability), with a score of 98 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Indivior Pharmaceuticals, Inc.?
Price (valuation), with a score of 39 out of 100: weaker than most similar companies.
Has Indivior Pharmaceuticals, Inc.'s PosiPenta changed since last week?
Yes, it rose 11.39 points, from 56.70 to 68.09.
PositoAI is for research and education only and is not investment advice.